A Typology of Intellectual Property Management for Public Health Innovation and Access: Design Considerations for Policymakers§
Identifieur interne : 000700 ( Ncbi/Checkpoint ); précédent : 000699; suivant : 000701A Typology of Intellectual Property Management for Public Health Innovation and Access: Design Considerations for Policymakers§
Auteurs : Antony TaubmanSource :
- The Open AIDS Journal ; 2010.
Abstract
This paper seeks to set the practical discipline of public interest intellectual property (IP) management in public health into its broader policy context. The most immediate and direct impact of IP systems on public welfare results not from international standards nor from national legislation – though these norms are fundamentally important - but rather from the accumulated impact of numerous practical choices whether or not to seek IP protection; where and where not; and how any exclusive rights are deployed, by whom, and to what end. IP management is the essentially practical exercise of limited exclusive rights over protected subject matter, the judicious use of those rights to leverage outcomes that advance an institution's or a firm's objectives. Exclusive rights are used to construct and define knowledge-based relationships, to leverage access to technology and other necessary resources, and to enhance market-based incentives. IP management choices range across a broad spectrum, spanning public domain strategies, open or exclusive licensing, and strong exclusivity. The idea of ‘exclusive rights’, as a specific legal mechanism, can run counter to expectations of greater openness and accessibility, but actual outcomes will depend very much on how these mechanisms are used in practice. For public interest or public sector institutions concerned with health research and development, particularly the development of new medicines, IP management choices can be just as critical as they are for private firms, although a predominant institutional concentration on advancing direct public interest objectives may lead to significantly different approaches in weighing and exercising practical choices for IP management: even so, a private sector approach should not be conflated with exclusivity as an end in itself, nor need public interest IP management eschew all leverage over IP. This paper offers a tentative framework for a richer typology of those choices, to give a sense of practical options available and the factors that might guide their application, but without advocating any particular approach.
Url:
DOI: 10.2174/1874613601004020004
PubMed: 20517487
PubMed Central: 2878976
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000E55
- to stream Pmc, to step Curation: 000E55
- to stream Pmc, to step Checkpoint: 000328
- to stream Ncbi, to step Merge: 000700
- to stream Ncbi, to step Curation: 000700
Links to Exploration step
PMC:2878976Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Typology of Intellectual Property Management for Public Health Innovation and Access: Design Considerations for Policymakers<xref ref-type="fn" rid="fn1">§</xref>
</title>
<author><name sortKey="Taubman, Antony" sort="Taubman, Antony" uniqKey="Taubman A" first="Antony" last="Taubman">Antony Taubman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">20517487</idno>
<idno type="pmc">2878976</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878976</idno>
<idno type="RBID">PMC:2878976</idno>
<idno type="doi">10.2174/1874613601004020004</idno>
<date when="2010">2010</date>
<idno type="wicri:Area/Pmc/Corpus">000E55</idno>
<idno type="wicri:Area/Pmc/Curation">000E55</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000328</idno>
<idno type="wicri:Area/Ncbi/Merge">000700</idno>
<idno type="wicri:Area/Ncbi/Curation">000700</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000700</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A Typology of Intellectual Property Management for Public Health Innovation and Access: Design Considerations for Policymakers<xref ref-type="fn" rid="fn1">§</xref>
</title>
<author><name sortKey="Taubman, Antony" sort="Taubman, Antony" uniqKey="Taubman A" first="Antony" last="Taubman">Antony Taubman</name>
</author>
</analytic>
<series><title level="j">The Open AIDS Journal</title>
<idno type="e-ISSN">1874-6136</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>This paper seeks to set the practical discipline of public interest intellectual property (IP) management in public health into its broader policy context. The most immediate and direct impact of IP systems on public welfare results not from international standards nor from national legislation – though these norms are fundamentally important - but rather from the accumulated impact of numerous practical choices whether or not to seek IP protection; where and where not; and how any exclusive rights are deployed, by whom, and to what end. IP management is the essentially practical exercise of limited exclusive rights over protected subject matter, the judicious use of those rights to leverage outcomes that advance an institution's or a firm's objectives. Exclusive rights are used to construct and define knowledge-based relationships, to leverage access to technology and other necessary resources, and to enhance market-based incentives. IP management choices range across a broad spectrum, spanning public domain strategies, open or exclusive licensing, and strong exclusivity. The idea of ‘exclusive rights’, as a specific legal mechanism, can run counter to expectations of greater openness and accessibility, but actual outcomes will depend very much on how these mechanisms are used in practice. For public interest or public sector institutions concerned with health research and development, particularly the development of new medicines, IP management choices can be just as critical as they are for private firms, although a predominant institutional concentration on advancing direct public interest objectives may lead to significantly different approaches in weighing and exercising practical choices for IP management: even so, a private sector approach should not be conflated with exclusivity as an end in itself, nor need public interest IP management eschew all leverage over IP. This paper offers a tentative framework for a richer typology of those choices, to give a sense of practical options available and the factors that might guide their application, but without advocating any particular approach.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Frank, J" uniqKey="Frank J">J Frank</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Lincoln, A" uniqKey="Lincoln A">A Lincoln</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="A Rawls, J" uniqKey="A Rawls J">J a) Rawls</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Marshall, A" uniqKey="Marshall A">A Marshall</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Taubman, As" uniqKey="Taubman A">AS Taubman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Taubman, A" uniqKey="Taubman A">A Taubman</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Eggerston, L" uniqKey="Eggerston L">L Eggerston</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Mayor, S" uniqKey="Mayor S">S Mayor</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Rusconi, We" uniqKey="Rusconi W">WE Rusconi</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Ganguli, P" uniqKey="Ganguli P">P Ganguli</name>
</author>
<author><name sortKey="Prickril, B" uniqKey="Prickril B">B Prickril</name>
</author>
<author><name sortKey="Khanna, R" uniqKey="Khanna R">R Khanna</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bremer, Hw" uniqKey="Bremer H">HW Bremer</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="A Nishtar, S" uniqKey="A Nishtar S">S a)Nishtar</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Gwatkin, Dr" uniqKey="Gwatkin D">DR Gwatkin</name>
</author>
<author><name sortKey="Guillot, M" uniqKey="Guillot M">M Guillot</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Merz, Fj" uniqKey="Merz F">FJ Merz</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Taubman, A" uniqKey="Taubman A">A Taubman</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Boulet, P" uniqKey="Boulet P">P Boulet</name>
</author>
<author><name sortKey="Garrison, C" uniqKey="Garrison C">C Garrison</name>
</author>
<author><name sortKey="T Oen, E" uniqKey="T Oen E">E t’Hoen</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Kettler, H" uniqKey="Kettler H">H Kettler</name>
</author>
<author><name sortKey="Towse, A" uniqKey="Towse A">A Towse</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Taubman, Antony" sort="Taubman, Antony" uniqKey="Taubman A" first="Antony" last="Taubman">Antony Taubman</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000700 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000700 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Musique |area= OperaV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= PMC:2878976 |texte= A Typology of Intellectual Property Management for Public Health Innovation and Access: Design Considerations for Policymakers§ }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:20517487" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a OperaV1
![]() | This area was generated with Dilib version V0.6.21. | ![]() |